Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cardiogenic Shock: early-phase trial registry
14 of 17 indexed Cardiogenic Shock trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,004 of 28,707 conditions by registered trial count.
17 US clinical trials · 14 currently recruiting · #1,004 of 28,707 conditions by registered trial count
Cardiogenic Shock: 17 US clinical trials tracked, 14 recruiting.
Cardiogenic Shock is the subject of 17 registered US clinical trials on ClinicalTrials.gov, 14 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Tufts Medical Center, running 3 of these trials.
Enrollment posture brief
Registry condition cardiogenic-shock
OPEN 14 | RECR 82% | LATE 0 | EARLY 4 | RANK #1004 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Stargardt Disease (82% recruiting · 17 trials)
Cardiogenic Shock lists 14 open slots (82% of 17 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cardiogenic Shock on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cardiogenic Shock is recruiting above its size-band peers.
14 of 17 indexed trials (82.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Cardiogenic Shock research.
Tufts Medical Center accounts for 3 of 17 trials (17.6%). 14 distinct sponsors appear on at least one study for this condition label.
-
Typical Cardiogenic Shock enrolment sits around 104 participants.
Median target enrolment is 104 among the 17 trials that report a genuine target (sentinel values excluded). 8 of those (47.1%) plan for fewer than 100 participants.
-
Cardiogenic Shock splits between interventional and observational designs.
8 interventional and 9 observational studies make up this index (47.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
17 total, page 1 of 1
Cardiogenic Shock Working Group Registry
Tufts Medical Center
NCT04682483
Inova Cardiogenic Shock Registry (INOVA SHOCK)
Inova Health Care Services
NCT03378739
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
Stavros G Drakos
NCT05185492
Pulmonary Artery Catheter in Cardiogenic Shock Trial
Tufts Medical Center
NCT05485376
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
University of Minnesota
NCT05426083
Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock
Ottawa Heart Institute Research Corporation
NCT05298124
Physiology of Unloading VA ECMO Trial
University of Utah
NCT06336655
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
Tufts Medical Center
NCT06253104
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Stanford University
NCT06080074
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
Inova Health Care Services
NCT04419480
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR
Atlantic Health System
NCT07309029
Augmented Pacing for Shock in the Cardiac Intensive Care Unit
Vanderbilt University Medical Center
NCT06713668
Intra-aortic Balloon Counterpulsation (IABC) Compliance
Thomas Jefferson University
NCT07402018
Cardiac Power Output in Cardiogenic Shock Patients
University of Chicago
NCT05700617
A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
Windtree Therapeutics
NCT05975021
National Cardiogenic Shock Initiative
Henry Ford Health System
NCT03677180
PPCM Observational Study (Peripartum Cardiomyopathy)
Medical College of Wisconsin
NCT04234659
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Cardiogenic Shock records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cardiogenic Shock trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cardiogenic Shock page
17 registered trials, 14 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 14 Cardiogenic Shock trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Tufts Medical Center sponsors the most Cardiogenic Shock trials on record, review their full trial history before evaluating a specific study. See Tufts Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cardiogenic Shock condition card totals 17 registered trials; most-linked intervention Clinical placement of a temporary IMPELLA® mechanical circulatory support device.; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.